DesoFace Fat Dissolver 10ml Vial 5 x 10ml Box

Deso

Aesthetic medicine injectable

Facial fat-dissolving (lipolytic) injection

Distributed in the UK as a CE Marked medical/aesthetic device for subcutaneous fat Dissolving injection.
Manufactured under ISO 13485 Compliant medical device quality systems.
Professional Use only, requiring appropriate qualifications per UK aesthetic and medical regulations.
Full batch traceability and controlled supply chain via authorised distributors such as Two Face Aesthetics.

Distributed in the UK as a CE Marked medical/aesthetic device for subcutaneous fat Dissolving injection.
Manufactured under ISO 13485 Compliant medical device quality systems.
Professional Use only, requiring appropriate qualifications per UK aesthetic and medical regulations.
Full batch traceability and controlled supply chain via authorised distributors such as Two Face Aesthetics.

Facial fat-dissolving (lipolytic) injection

Description

DesoFace is a state-of-the-art fat-dissolving injectable solution specifically formulated to target small, localised pockets of facial fat. It uses deoxycholic acid—the same clinically established active ingredient found in Aqualyx® and other intralipotherapy products—to break down adipocytes by disrupting their membrane integrity. The liquified fat is then gradually removed through the lymphatic system. Known for causing significantly less swelling than Aqualyx®, DesoFace is ideal for delicate facial areas such as the chin, jawline, lower cheeks and jowls. The product is supplied as a sterile solution to be drawn into a small syringe and administered via multiple subcutaneous injections by trained practitioners. Each treatment typically takes 20–30 minutes, requires minimal downtime, and may make use of a compression garment depending on the injection area. Two Face Aesthetics offers DesoFace as either a single 10 ml vial or as a box of five vials for clinic use.

Bnefits

Targets small, stubborn facial fat deposits (e.g. chin, jawline, jowls).
Utilises deoxycholic acid, a proven lipolytic agent that destroys adipocytes for long-term fat reduction.
Reported to cause less swelling than Aqualyx®, resulting in improved patient comfort.
Non-surgical alternative to liposuction for suitable candidates.
Quick procedure time (20–30 minutes) with minimal downtime.
Suitable for fine contouring and precise treatment in small facial areas.
Available as a single vial or a pack of five, supporting both occasional and high-volume clinic use.
When fat cells are destroyed they do not return, making results effectively permanent with stable weight.
Compatible with local anaesthetic to enhance comfort during injection.

Indications

Localised facial and submental (double chin) fat deposits.
Jawline and lower cheek contouring.
Treatment of small stubborn fat pockets on the face that are resistant to diet and exercise.
Patients seeking non-surgical facial sculpting and definition.
Submental fullness reduction in adults with stable body weight.

Composition

Formulation

Sterile aqueous injectable solution intended for subcutaneous fat-dissolving injections in the face.
Deoxycholic acid in a lower, facial-safe concentration to minimise irritation while maintaining lipolytic efficacy.
Designed to liquify and break down small, localised fat deposits for gradual lymphatic clearance.
Non-animal origin raw materials; high-purity pharmaceutical-grade formulation.
For professional use only.

Packaging

Supplied as either: 1 × 10 ml vial OR 5 × 10 ml vials (clinic box).
Each vial is sealed, sterile and intended for single-patient use once opened.
Packaged in a branded carton showing batch number, expiry date and professional-use labelling.
Accompanied by instructions and safety information provided by the distributor.

Usage

DesoFace must only be administered by licensed healthcare or aesthetic professionals trained in intralipotherapy and facial anatomy.
Pre-treatment preparation:
• Assess patient suitability; rule out contraindications.
• Clean and disinfect the skin thoroughly.
• Draw the product into a sterile syringe; may be mixed with local anaesthetic according to clinic protocol.
Injection method:
• Inject subcutaneously only; avoid intradermal or intramuscular injection.
• Use multiple small injections across the treatment area (e.g. chin, jawline) for even distribution.
• Treatment duration is typically 20–30 minutes.
• Do not exceed recommended volume per session; adjust dosing to facial area size.
Aftercare guidance:
• Localised redness, swelling and tiny puncture marks are expected after treatment.
• Avoid strenuous activity, extreme heat and sun exposure for 24–48 hours.
• A compression garment may be recommended in some cases (e.g. submental region).
• Do not apply makeup for at least 12–24 hours post-treatment unless advised otherwise.
• Follow all post-care instructions from the treating practitioner.
Treatment schedule:
• Treatments are usually spaced 4–6 weeks apart.
• Most patients require 2–4 sessions depending on the size of the fat pocket and individual response.

Contraindications

Hypersensitivity to deoxycholic acid or any component of the formulation.
Pregnancy or breastfeeding.
Patients under 18 years of age.
Generalised obesity (DesoFace is not a weight-loss treatment).
Active local infection, inflammation or dermatitis at the intended injection site.
Severe autoimmune conditions or compromised immune systems.
Bleeding disorders or use of anticoagulant medications unless assessed and cleared.
Severe metabolic, hepatic or renal disease unless approved by a physician.
History of severe allergic reactions to injectable agents.
Very thin submental or facial skin where safe injection depth cannot be ensured.

Adverse Effects

Expected temporary effects: redness, swelling, bruising, tenderness, warmth and small nodules in the treated area.
Possible: itching, temporary numbness or altered sensitivity, firmness or lumpiness as the fat breaks down.
Less common: local infection or cellulitis if aseptic technique is not followed.
Rare: persistent nodules, uneven results, excessive inflammation requiring medical attention.
Very rare: vascular events, tissue necrosis or nerve injury due to incorrect injection depth or technique.
Allergic reactions to deoxycholic acid or preservatives are possible, though uncommon.

Storage Conditions

Store in a cool, dry environment as directed by manufacturer (generally 2°C–25°C).
Protect vials from direct light and heat.
Do not freeze.
Keep vials in original packaging until use.
Do not use if packaging or vial integrity is compromised or if the solution appears discoloured.
Dispose of opened vials and sharps according to clinical waste regulations.

Duration

Treatment is performed in 20\u201330 minute sessions, typically over 2\u20134 separate visits spaced 4\u20136 weeks apart. Results are long-lasting, with fat cells permanently removed once destroyed. Maintenance sessions may be performed if new fat accumulates due to lifestyle factors.

Onset

Initial swelling subsides within several days. Visible improvement often appears within 3\u20134 weeks, with full results usually achieved 6\u20138 weeks after the final session.